-
NextCure Inc. (NXTC $4.92)
- $4.92 Cap: $11M
- View NXTC Profile
- View Questions on NXTC
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Amgen Inc. (AMGN $305.69)
- $305.69 P/E (TTM): 26.97X Cap: $159.09B
- View AMGN Profile
- View Questions on AMGN
-
Regeneron Pharmaceuticals Inc. (REGN $560.93)
- $560.93 P/E (TTM): 13.87X Cap: $58.89B
- View REGN Profile
- View Questions on REGN
-
Vertex Pharmaceuticals Incorporated (VRTX $470.13)
- $470.13 Cap: $117.73B
- View VRTX Profile
- View Questions on VRTX
-
iShares Biotechnology ETF (IBB $132.84)
- $132.84 P/E (TTM): 41.5X Cap: $5.30B
- View IBB Profile
- View Questions on IBB
-
Mettler-Toledo International Inc. (MTD $1,218.96)
- $1,218.96 P/E (TTM): 29.13X Cap: $24.24B
- View MTD Profile
- View Questions on MTD
-
Solid Biosciences Inc. (SLDB $6.23)
- $6.23 Cap: $432M
- View SLDB Profile
- View Questions on SLDB
-
TCR2 Therapeutics Inc. (TCRR)
- Cap: $58M
- View TCRR Profile
- View Questions on TCRR
-
NextCure Inc. (NXTC $4.92)
- $4.92 Cap: $11M
- View NXTC Profile
- View Questions on NXTC
Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?
-
NextCure Inc. (NXTC $4.92)
- $4.92 Cap: $11M
- View NXTC Profile
- View Questions on NXTC
Q: Can you comment about this US drug Co. developing immuno-medicines for Cancer.
Insiders
Share Information
SEC Filings
News and Media